全球癌症登记软体市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

预计 2025 年至 2033 年间，全球癌症登记软体市场将以 12.84% 的显着复合年增长率成长。到 2033 年，市场规模预计将飙升至 2.6856 亿美元，较 2024 年的 9,055 万美元大幅成长。

随着全球医疗保健系统将数据驱动的肿瘤管理和研究置于优先地位，癌症登记软体市场有望加速成长。这些软体解决方案有助于系统地收集、储存和分析癌症患者资料，从而改善流行病学追踪、治疗计划和疗效评估。云端运算、巨量资料分析和互通性标准的进步正在增强癌症登记平台的可扩展性、可访问性和整合能力。这项技术进步支持医院、研究机构和公共卫生机构之间的即时资料共享，促进癌症控制和个人化医疗的合作。

人工智慧和机器学习演算法越来越多地嵌入到註册软体中，用于识别模式、预测疾病进展和优化资源分配。增强资料安全性并遵守 HIPAA 和 GDPR 等医疗保健法规至关重要，可确保患者的隐私和信任。电子健康记录 (EHR) 和健康资讯交换 (HIE) 的日益普及正在推动无缝资料集成，减少人工输入错误并提高资料准确性。此外，使用者友善的介面和可自订的报告工具​​使临床医生和研究人员能够有效率地获得切实可行的见解。

软体开发人员、肿瘤学专家和政府机构之间的合作正在加速癌症登记解决方案的创新和标准化。随着全球癌症发生率的上升和精准肿瘤学的进步，癌症登记软体对于有效的疾病监测、临床决策和政策制定而言正变得不可或缺，最终将改善患者治疗效果并提高医疗保健系统的效率。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概况：对市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新和潜在投资领域。本部分提供对未来市场发展和成长前景的洞察。

涵盖的细分市场列表

癌症登记软体市场报告的此部分提供了国家和地区层面的细分详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按软体

• 独立
• 融合的

按部署模型

• 本地部署
• 基于云端

按组件

• 商业的
• 民众

按最终用途

• 政府与第三方
• 私人付款人
• 医院和医疗机构
• 製药生物技术和医疗器材公司
• 研究机构
• 报告中介绍的公司列表
• Elekta AB、Oracle Corporation、ONCO Inc.、国际商业机器公司 (IBM)、McKesson Corporation、Conduent Incorporated、Ordinate Corporation、Volpara Health Technologies Limited、Health Catalyst Inc.、Rocky Mountain Cancer Data Systems（犹他大学健康中心）

如果您有任何客製化需求，请联络我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：癌症登记软体 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 软体市场吸引力分析
  • 按部署模型进行市场吸引力分析
  • 各组成部分的市场吸引力分析
  • 按最终用途进行的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球癌症登记软体市场分析：按软体

• 按软体概览
• 透过软体进行历史和预测数据分析
• 独立
• 融合的

第六章：全球癌症登记软体市场分析：依部署模型

• 按部署模型概述
• 按部署模型进行历史和预测资料分析
• 本地部署
• 基于云端

第七章：全球癌症登记软体市场分析：按组件

• 按组件概览
• 按组件进行历史和预测资料分析
• 商业的
• 民众

第 8 章：全球癌症登记软体市场分析：依最终用途

• 按最终用途概述
• 按最终用途进行的历史和预测数据分析
• 政府与第三方
• 私人付款人
• 医院和医疗机构
• 製药生物技术和医疗器材公司
• 研究机构

第九章：全球癌症登记软体市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 10 章：癌症登记软体公司的竞争格局

• 癌症登记软体市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Elekta AB
• 公司概况
• 公司收入
• 产品
• 最新动态
• Oracle Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• ONCO Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• International Business Machines Corporation (IBM)
• 公司概况
• 公司收入
• 产品
• 最新动态
• McKesson Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Conduent Incorporated
• 公司概况
• 公司收入
• 产品
• 最新动态
• Ordinate Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Volpara Health Technologies Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Health Catalyst Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Rocky Mountain Cancer Data Systems (University Of Utah Health)
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

The Global Cancer Registry Software market is forecasted to grow at a noteworthy CAGR of 12.84% between 2025 and 2033. By 2033, market size is expected to surge to USD 268.56 Million, a substantial rise from the USD 90.55 Million recorded in 2024.

The cancer registry software market is poised for accelerated growth as healthcare systems worldwide prioritize data-driven oncology management and research. These software solutions facilitate the systematic collection, storage, and analysis of cancer patient data, enabling improved epidemiological tracking, treatment planning, and outcome assessment. Advances in cloud computing, big data analytics, and interoperability standards are enhancing the scalability, accessibility, and integration capabilities of cancer registry platforms. This technological evolution supports real-time data sharing among hospitals, research institutions, and public health agencies, fostering collaborative efforts in cancer control and personalized medicine.

Artificial intelligence and machine learning algorithms are increasingly embedded within registry software to identify patterns, predict disease progression, and optimize resource allocation. Enhanced data security and compliance with healthcare regulations such as HIPAA and GDPR are critical features, ensuring patient confidentiality and trust. The growing adoption of electronic health records (EHR) and health information exchanges (HIE) is driving seamless data integration, reducing manual entry errors and improving data accuracy. Additionally, user-friendly interfaces and customizable reporting tools are empowering clinicians and researchers to derive actionable insights efficiently.

Collaborations between software developers, oncology experts, and government bodies are accelerating innovation and standardization in cancer registry solutions. As cancer incidence rises globally and precision oncology advances, cancer registry software is becoming indispensable for effective disease surveillance, clinical decision-making, and policy formulation, ultimately enhancing patient outcomes and healthcare system efficiency.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Cancer Registry Software market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Software

• Standalone
• Integrated

By Deployment Model

• On-premise
• Cloud Based

By Component

• Commercial
• Public

By End-use

• Government & Third Party
• Private Payers
• Hospital & Medical Practice
• Pharma Biotech & Medical Device Companies
• Research Institutes
• List of Companies Profiled in the report
• Elekta AB, Oracle Corporation, ONCO Inc., International Business Machines Corporation (IBM), McKesson Corporation, Conduent Incorporated, Ordinate Corporation, Volpara Health Technologies Limited, Health Catalyst Inc., Rocky Mountain Cancer Data Systems (University of Utah Health)

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CANCER REGISTRY SOFTWARE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Software
  • 3.7.2 Market Attractiveness Analysis By Deployment Model
  • 3.7.3 Market Attractiveness Analysis By Component
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY SOFTWARE

• 5.1. Overview By Software
• 5.2. Historical and Forecast Data Analysis By Software
• 5.3. Standalone Historic and Forecast Sales By Regions
• 5.4. Integrated Historic and Forecast Sales By Regions

6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY DEPLOYMENT MODEL

• 6.1. Overview By Deployment Model
• 6.2. Historical and Forecast Data Analysis By Deployment Model
• 6.3. On-premise Historic and Forecast Sales By Regions
• 6.4. Cloud Based Historic and Forecast Sales By Regions

7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY COMPONENT

• 7.1. Overview By Component
• 7.2. Historical and Forecast Data Analysis By Component
• 7.3. Commercial Historic and Forecast Sales By Regions
• 7.4. Public Historic and Forecast Sales By Regions

8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-use
• 8.2. Historical and Forecast Data Analysis By End-use
• 8.3. Government & Third Party Historic and Forecast Sales By Regions
• 8.4. Private Payers Historic and Forecast Sales By Regions
• 8.5. Hospital & Medical Practice Historic and Forecast Sales By Regions
• 8.6. Pharma Biotech & Medical Device Companies Historic and Forecast Sales By Regions
• 8.7. Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CANCER REGISTRY SOFTWARE COMPANIES

• 10.1. Cancer Registry Software Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF CANCER REGISTRY SOFTWARE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Elekta AB
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Oracle Corporation
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. ONCO Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. International Business Machines Corporation (IBM)
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. McKesson Corporation
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Conduent Incorporated
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Ordinate Corporation
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Volpara Health Technologies Limited
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Health Catalyst Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Rocky Mountain Cancer Data Systems (University Of Utah Health)
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Software (USD MN)
• Standalone Market Sales By Geography (USD MN)
• Integrated Market Sales By Geography (USD MN)
• Analysis By Deployment Model (USD MN)
• On-premise Market Sales By Geography (USD MN)
• Cloud Based Market Sales By Geography (USD MN)
• Analysis By Component (USD MN)
• Commercial Market Sales By Geography (USD MN)
• Public Market Sales By Geography (USD MN)
• Analysis By End-use (USD MN)
• Government & Third Party Market Sales By Geography (USD MN)
• Private Payers Market Sales By Geography (USD MN)
• Hospital & Medical Practice Market Sales By Geography (USD MN)
• Pharma Biotech & Medical Device Companies Market Sales By Geography (USD MN)
• Research Institutes Market Sales By Geography (USD MN)
• Global Cancer Registry Software Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cancer Registry Software Report
• Market Research Process
• Market Research Methodology
• Global Cancer Registry Software Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Software
• Market Attractiveness Analysis By Deployment Model
• Market Attractiveness Analysis By Component
• Market Attractiveness Analysis By End-use
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Software (USD MN)
• Standalone Market Sales By Geography (USD MN)
• Integrated Market Sales By Geography (USD MN)
• Global Market Analysis By Deployment Model (USD MN)
• On-premise Market Sales By Geography (USD MN)
• Cloud Based Market Sales By Geography (USD MN)
• Global Market Analysis By Component (USD MN)
• Commercial Market Sales By Geography (USD MN)
• Public Market Sales By Geography (USD MN)
• Global Market Analysis By End-use (USD MN)
• Government & Third Party Market Sales By Geography (USD MN)
• Private Payers Market Sales By Geography (USD MN)
• Hospital & Medical Practice Market Sales By Geography (USD MN)
• Pharma Biotech & Medical Device Companies Market Sales By Geography (USD MN)
• Research Institutes Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.